TX-HYOSUNG-AMERICA
Hyosung America announced today that DigitalMint , the premier cash-to-cryptocurrency provider, has signed a partnership agreement with Hyosung America to add DigitalMint services to its soon-to-be-launched API-based app store.
As the leading Bitcoin point-of-sale provider in the nation, DigitalMint allows customers to buy cryptocurrency instantly at ATM and teller locations across the United States. They've also developed a software API integration that enables retailers to sell Bitcoin through their current point-of-sale system. DigitalMint, founded in 2014, can be found in financial service centers, convenience stores, grocery chains, gas stations, and retail locations across the country.
“We’re thrilled to be the first product on the upcoming Hyosung app store,” said Don Wyper, Chief Operating Officer of DigitalMint, “We're looking forward to working with Hyosung America to make cryptocurrency services easily and safely accessible to their 175,000 deployed ATMs in the United States and beyond.”
“Our nationwide distribution scale and relationships with top ATM value-added resellers and independent operators provides DigitalMint with unprecedented scale for its growing customer base,” said Hee-Eun Ahn, CEO for Hyosung America.
“We are excited to include DigitalMint into our soon-to-be-launched app store. With the app store, any ATM operator using our retail software platform can subscribe and download apps such as DigitalMint, to enable their ATMs to do more – driving new revenue streams for the operators and the retailers with whom they partner,” said Brad Nolan, CMO for Hyosung America. “This is as easy as an app download in our new Series X Metakiosks, and in conjunction with our newly launched X10 Cash-In-Sidecar, any Hyosung cash dispenser can instantly transform into a full function device and tap into a whole new universe of transactions including bill pay, check cashing, cash deposits, POS purchase and of course cryptocurrency purchase.”
The company plans to launch their DigitalMint partnership and new products in a live webinar on Tuesday, July 12 at 2 p.m. CT. Registration for that webinar, which will remain on the site following the live stream, can be found here: https://marketscale.com/live/hyosung-summer-2022-retail-product-launch/ .
About Hyosung America
Hyosung America, the world’s leading cash management and payments platform service provider, is the North American subsidiary of South Korea-based Hyosung, Inc. Since entering the North American market in 1998, Hyosung has grown from the largest provider of ATMs in the United States, to offering best-in-class, innovative and transformative technology solutions across the cash management and payments spectrum. Hyosung America is headquartered in Irving, Texas, and provides research and development support in its Global Software Center in Dayton, Ohio.
About DigitalMint
DigitalMint is the premier cash-to-cryptocurrency provider, enabling consumers to buy cryptocurrency safety and securely through our nationwide network of ATMs and tellers. Our mission is to empower consumers to take control of their financial future by utilizing digital currencies as a tool for financial access. Founded in 2014, DigitalMint is an industry leader in cryptocurrency compliance standards, providing safe and secure access to cryptocurrencies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220712005368/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FIM Partners and Loomis Sayles Announce Transition of Global Emerging Market Equities Team6.11.2025 14:00:00 CET | Press release
FIM Partners today announced it has entered into an agreement with Loomis, Sayles & Company, to acquire the Global Emerging Market Equities (GEM) investment team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106799715/en/ Overview of the GEM Team and FIM Led by Ashish Chugh, Portfolio Manager and Head of Global Emerging Market Equities, the GEM Team follows a high conviction investment philosophy anchored in deep, fundamental research and a private equity-style approach to diligence and ownership. The team invests in high quality companies and those transitioning toward higher quality, leveraging its proprietary insights to identify long-term value creation opportunities across emerging markets. With an active, bottom-up, benchmark-agnostic strategy, the team builds high-conviction, concentrated, quality-focused portfolios that reflect a true ownership mindset. Founded in 2008, FIM Partners is a leading asset manager fo
IFCO’s circular model delivers global impact: Five years of progress marked with 2025 ESG report6.11.2025 14:00:00 CET | Press release
Over 10 billion single-use boxes replaced with reusable packaging in global fresh grocery supply chains IFCO, a global leader in reusable packaging containers (RPCs) for fresh food, today published its ESG Report 2025, marking the successful completion of its five-year sustainability strategy, Thriving in the Circular Economy. Over the last five years, IFCO has advanced every one of its 18 ESG goals, delivering measurable progress for the planet, people, partners, and customers while laying the groundwork for the next iteration of its sustainability objectives. The ESG Report 2025 confirms IFCO’s position as a global leader in circular packaging and highlights the role of reuse in addressing some of the sector’s most pressing challenges. Since IFCO’s founding in 1992, it has dedicated itself to eliminating packaging and food waste in the fresh grocery supply chain, enhancing efficiencies across the value chain and sharing the resulting long-term value with stakeholders. With operations
Debiopharm Takes a Step Forward for Children With CPP: Enrollment Completion for the Phase III Trial Evaluating the First Ever Yearly Injectable Triptorelin Formulation6.11.2025 14:00:00 CET | Press release
LIBELULATM trial completed enrollment of Central Precocious Puberty (CPP) patients in North and South America, advancing the path for Debio 4326, a triptorelin injectable 12-month extended-release formulation Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to develop innovative therapies and to improve patient quality of life, today announced the successful completion of patient enrollment in its open-label, single-arm, multi-center Phase III study (NCT06129539) ‘A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULATM)’. The completion of enrollment is a significant milestone for the development of Debio 4326, a unique injectable, biodegradable 12-month extended-release formulation of the established treatment, triptorelin. The LIBELULATM trial is being conducted across the United States, Argenti
U.K. Continues to Lead Europe in Shareholder Activism with 44% Year-on-Year Surge, According to Diligent Market Intelligence6.11.2025 13:00:00 CET | Press release
As the U.K. Market Fuels Growing Interest from Domestic and International Activists, Investors Have Adapted their Approach to Gain Access to Boardrooms in Germany and Italy The U.K. remains Europe’s most active market for shareholder activism, with a 44% year-on-year increase in targeted companies, according to the Corporate Governance in Europe 2025report by Diligent Market Intelligence (DMI). Between September 2024 and August 2025, 52 U.K. companies faced activism, compared to 36 over the same timeframe in 2024, underscoring the market’s heightened shareholder engagement. “The U.K. remains the primary driver of public-facing engagement in Europe, with other European markets increasingly witnessing similar strategies when behind-the-scenes efforts fail,” said Josh Black, Editor-in-Chief, Diligent Market Intelligence. “Activism in Europe runs the full gamut from hostile media campaigns to more private engagements but there is no doubt that boards should prepare for anything in what loo
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates6.11.2025 12:00:00 CET | Press release
Third quarter total revenues increased 41% to $1.4 billion versus third quarter 2024Global BRUKINSA® (zanubrutinib) revenues increased 51% to $1.0 billion versus third quarter 2024Diluted GAAP Earnings per American Depository Share (ADS) of $1.09, non-GAAP diluted Earnings per ADS of $2.6547 abstracts accepted at American Society of Hematology (ASH) Annual Meeting BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter of 2025. “These strong financial results reinforce our position as a global oncology leader with exceptional topline growth and a strong balance sheet,” said John V. Oyler, Co-Founder, Chairman and CEO at BeOne. “BRUKINSA is now the global revenue leader in the BTKi class, supported by long-term efficacy and safety data and a growing body of evidence reinforcing its scientific hypothesis of sustained BTK inhibition. Our late-stage hematology portfolio continues
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom